Table 2: Analysis of relative biochemical indicators.

GroupControl groupPrediabetes groupsNewly diagnosed type 2 diabetes group value value

Number of patients (M/F)33 (12/21)33 (12/21)43 (25/18)
FPG 72.87a .001*
PPG 90.78a .001*
DPG 78.85a .001*
HbA1C (%) 67.02a .001*
GA 75.93a .001*
TC 2.44a.296
TG 5.78a.056
LDL-C 0.48.618
HDL-C 6.27a.043**
HOMA-IRI 7.68a.022**
HOMA-β 5.35a.069

FPG: fasting plasma glucose; PPG: postprandial plasma glucose; DPG: diphosphoglycerate plasma glucose; HbA1C: glycosylated haemoglobin; GA: glycated albumin; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HOMA-IRI: homeostasis model method of assessment-insulin resistance index; HOMA-β: homeostasis model method of assessment β-cell function.
aNonparametric analysis method used.
*Significant among the 3 groups.
**Significant between newly diagnosed type 2 diabetes and control group.